BILL · 2007–08 SESSION
HB 2346: Clinical trials
Extending the business and occupation tax credit provided for qualified research and development to persons performing both phase I and II clinical trials.
Summary
- Extends the business and occupation tax credit provided for qualified research and development to persons performing both phase I and II clinical trials.
From the Bill Digest (HB 2346), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedFeb 22, 2007
- Out of committeestopped here
- Passed House
- Passed Senate
- Governor
- Law
- Prime sponsor
- Jeannie Darneille (D-27)
- Introduced
- February 22, 2007 in the House
- Last action
- January 14, 2008
AN ACT Relating to extending the tax incentives provided for qualified research and development to persons performing both phase I and II clinical trials;
Sponsors
Prime sponsor: Jeannie Darneille (D-27)
6 co-sponsors (5 Democrats, 1 Republican)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- By resolution, reintroduced and retained in present status.
- First reading, referred to Finance.
HB 2346 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- HB 2346 (2025–26) Middle housing/perf. codes
- HB 2346 (2023–24) Health disparities council
- HB 2346 (2019–20) State rep. statements
- HB 2346 (2017–18) Adult family homes/priority
- HB 2346 (2015–16) Renewable energy promotion
- HB 2346 (2013–14) Fish passage barrier removal
- HB 2346 (2011–12) Correctional officer uniform
- HB 2346 (2009–10) Crisis residential centers